Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis

3m ·

Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis

Listen to FDA Drug Safety Podcast on due to risk of serious liver injury, FDA restricts use of Ocaliva in primary biliary cholangitis (PBC) patients with advanced cirrhosis

Login to see and leave a comments

  • Chris

    Love the podcast, good episode and clear audio! Keep these comming

    ·5 likes·
    Markus

    Insightful and timely. Heartfelt words of personal and intuitive wisdom. Matt speaks directly from his heart about life wisdom’s coming from experience and deep thought. I love it. Victoria Mcknight

    2 months ago·2 likes·
    Mario

    Very thought out! Can't wait to try it out.

    2 months ago·10 likes·
  • Daisyee

    @yames check this podcast out its a great one

    ·7 likes·
    Moriss

    @yames check this podcast out its a great one

    2 months ago·8 likes·
    Gillian

    10:30 --> 20:00 amazing bit

    2 months ago·1 like·
  • Daisyee

    Insightful and timely. Heartfelt words of personal and intuitive wisdom. Matt speaks directly from his heart about life wisdom’s coming from experience and deep thought. I love it. Victoria Mcknight

    ·6 likes·
    Sophie

    10:30 til around 20:00 is a great part

    2 months ago·6 likes·
    Mario

    Very thought out! Can't wait to try it out.

    2 months ago·9 likes·
    Lisaa

    6:00 who is the intro sooo long 😂

    2 months ago·6 likes·

Podcast hosts

No host has claimed this podcast yet, if you are the host you can verify ownership by claiming this podcast